Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001551350 | SCV001771836 | uncertain significance | not provided | 2020-04-03 | criteria provided, single submitter | clinical testing | Identified in a patient with intellectual disability and dysmorphic facies in published literature (Scocchia et al., 2019); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 30792901) |
Labcorp Genetics |
RCV003638797 | SCV004509635 | likely benign | Rubinstein-Taybi syndrome due to EP300 haploinsufficiency | 2024-10-17 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV003638797 | SCV004801610 | uncertain significance | Rubinstein-Taybi syndrome due to EP300 haploinsufficiency | 2017-09-01 | criteria provided, single submitter | clinical testing | The EP300 c.2876G>T p.(Ser959Ile) missense variant has not, to our knowledge, been reported in the peer-reviewed literature. This variant is reported in the Genome Aggregation Database in one allele at a frequency of 0.000029 in the Admixed American population (version 2.1.1). Based on the limited evidence, the c.2876G>T p.(Ser959Ile) variant is classified as a variant of uncertain significance for Rubinstein-Taybi syndrome. |